Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

Figure 2

Effect of DAC on the survival time of mice with L1210 lymphoid leukemia. CD2F1 mice received 1 × 104 L1210 leukemic cells on day 1. Chemotherapy was started on day 2 with the indicated doses of DAC for 18 h i.v. infusion. The survival time of mouse was monitored. Control: n = 10 ; DAC 2.5 mg/kg : n = 10 ; DAC 5 mg/kg : n = 19 ; DAC 10 mg/kg : n = 13 ; DAC 15 mg/kg : n = 12 ; DAC 20 mg/kg : n = 3.

Back to article page